Table 1.
Protein | Function |
---|---|
Bcl-2* | Anti-apoptotic, blocks Bax/Bak channel formation |
Bcl-XL | Anti-apoptotic, blocks Bax/Bak channel formation |
Bax* | Pro-apoptotic, forms pores for cytochrome c release |
Bak* | Pro-apoptotic, forms pores for cytochrome c release |
Bad | Pro-apoptotic, decoy for Bcl-2/Bcl-XL promoting Bax/Bak pore formation |
Bid | Pro-apoptotic, decoy for Bcl-2/Bcl-XL promoting Bax/Bak pore formation |
Noxa | Pro-apoptotic, decoy for Bcl-2/Bcl-XL promoting Bax/Bak pore formation |
Puma | Pro-apoptotic, decoy for Bcl-2/Bcl-XL promoting Bax/Bak pore formation |
p53* | Antagonizes activity of Bcl-2/Bcl-XL, promotes Bax/Bak oligomerization |
Cytochrome c | Activator of apoptosome |
Smac/DIABLO | IAP inhibitor |
AIF | Antioxidant flavoprotein/released from mitochondria to promote nuclear DNA fragmentation |
Endonuclease G | Released from mitochondria to promote nuclear DNA fragmentation |
HtrA2/Omi | IAP inhibitor |
VDAC | mPTP component in outer mitochondrial membrane |
ANT+ | mPTP component in inner mitochondrial membrane |
Cyclophilin D+ | mPTP component in mitochondrial matrix |
TSPO (peripheral benzodiazepine receptor) | Modulator of mPTP |
Hexokinase | Modulator of VDAC |
* Changes have been reported in human ALS (see below)
+ A reported target of oxidative modification in mouse ALS (see below)